Correction to: Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension (Advances in Therapy, (2018), 35, 6, (796-808), 10.1007/s12325-018-0718-9)

Suzuki K., Otsuka N., Hizaki H., Hashimoto M., Kuwayama Y., On behalf of the Tafluprost/Timolol Versus Latanoprost/Timolol (TTVLT) Study Group

2019
Advances in Therapy

View publication

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

Suzuki Eye Clinic, Yamaguchi, Japan; Santen Pharmaceutical Co., Ltd., Osaka, Japan; Fukushima Eye Clinic, Osaka, Japan

Related Publications

Posterior Ciliary Artery Contraction by Bradykinin Receptor Subtypes and Implications for Retinal Blood Flow Dysfunction

Sharif NA, Ohia SE, Kulkarni-Chitnis M, Okolie A, Chaudhry SD, Njie-Mbye YF

Associations between Clustered Visual Field Progression and Locations of Disc Hemorrhages in Glaucoma: A 3-Year Prospective Study

Akagi T, Fukuchi T, Higashide T, Udagawa S, Ohkubo S, Sugiyama K, Tanihara H, Araie M, Tomita G, Matsumoto C, Tomidokoro A, Hangai M, Kawata H, Inai M, Tanaka Y; SVF Prospector Study Group.

Cost-utility analysis of latanoprost unidose cationic emulsion preservative-free versus latanoprost unidose in the treatment of open-angle glaucoma and ocular hypertension patients in Spain

Canut MI, García-Feijoo J, Larrosa-Poves JM, López-López F, Pazos M, Espinoza-Cámac N, Oyagüez I, Del Rio T, Rodríguez M.

View all Glaucoma publications